The effect of Melissa officinalis on the treatment of children with attention deficit hyperactivity disorder

Study of the effectiveness of Melissa officinalis extract on the treatment of children with attention deficit hyperactivity disorder

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190330043139N1

Enrollment

Registered

2020-05-01

Start date

2018-12-22

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorder. Attention-deficit hyperactivity disorders

Interventions

Intervention 1: Control group: Placebo with a dose of 160 mg twice daily for 8 weeks. Intervention 2: Intervention group: Alcoholic extract of Melissa officinalis with a dose of 160 mg twice daily for

Eligibility

Sex/Gender

All

Age

6 Years to 15 Years

Inclusion criteria

Inclusion criteria: Children aged 6-15 years old Diagnosis of Attention deficit hyperactivity disorder(ADHD) based on Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition(DSM-V) Filling the consent form

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Patients with Attention deficit hyperactivity disorder (ADHD). Timepoint: Before starting the study and at 0, 4, and 8 weeks after starting treatment. Method of measurement: Integrated visual Auditory(IVA)- Conners-Clinical Q- Quantitative Electroencephalography (qEEG) tests.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Amir Houshang Mohammadpour

Mashhad University of Medical Sciences

V.pooria@yahoo.com+98 51331801

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026